Joint and Skin Symptoms Make Quality of Life Significantly Worse for Psoriatic Arthritis Patients
A study ascertained the effect of joint and skin symptoms on psoriatic arthritis (PsA) patients and found that they contribute significantly to poorer clinical...
Psoriatic Arthritis Detection in Psoriasis: How Can Rheumatologists Identify the Disease?
Early psoriatic arthritis detection can pose a challenge for rheumatologists—especially in the presence of psoriasis. A study assessed the correlation between serological markers and...
Rheum Round-up: Bimekizumab in Active PsA, Which Surgeries Result in ‘Surprise’ Medical Bills?, and...
Here are the top stories recently covered by DocWire News in the Rheumatology section. In this edition, read about the use of bimekizumab in...
Bimekizumab Is a Safe and Effective Treatment for Active Psoriatic Arthritis
The randomized, double-blind BE ACTIVE trial compared bimekizumab versus placebo in patients with active psoriatic arthritis. According to the findings, bimekizumab was associated with...
Rheum Round-up: Interview with Researchers, Which Patients Have More Medical Visits?, and more
Here are the top stories recently covered by DocWire News in the Rheumatology section. In this edition, read an interview with two researchers behind...
PsA Patients Have More Medical Visits in Five Years Leading Up to Diagnosis
A new study evaluated healthcare utilization among psoriatic arthritis (PsA) patients in the years leading up to their diagnosis. The researchers concluded here that...
Five-year Efficacy of Secukinumab in PsA
Patients with psoriatic arthritis (PsA) may observe improved long-term outcomes with secukinumab treatment, according to the results of a five-year study.
“Biologic therapies, such as...
